Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
BKD
|
Elizabeth B. Mace
Director |
BUY
Grant, award, or other acquisition
|
Direct | 17,469 Added 35.71% |
-
|
Feb 12
2025 |
CENT
|
Courtnee A Chun |
BUY
Grant, award, or other acquisition
|
Direct | 3,647 Added 19.9% |
-
|
Feb 12
2025 |
APO
|
John P. Zito
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 45,041 Reduced 1.48% |
$7,465,545
$165.75 p/Share
|
Feb 12
2025 |
BKH
|
Marne M Jones
SVP - Utilities |
SELL
Payment of exercise price or tax liability
|
Direct | 107 Reduced 0.3% |
$6,430
$60.1 p/Share
|
Feb 12
2025 |
BKH
|
Marne M Jones
SVP - Utilities |
BUY
Grant, award, or other acquisition
|
Direct | 254 Added 0.7% |
$15,265
$60.1 p/Share
|
Feb 12
2025 |
BKD
|
Denise Wilder Warren
Director |
BUY
Grant, award, or other acquisition
|
Direct | 32,454 Added 13.9% |
-
|
Feb 12
2025 |
CNP
|
Kristie Colvin
SVP and CAO |
BUY
Grant, award, or other acquisition
|
Direct | 4,098 Added 3.2% |
-
|
Feb 12
2025 |
BKH
|
Keller D Erik
Sr VP Chief Info Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 120 Reduced 1.14% |
$7,212
$60.1 p/Share
|
Feb 12
2025 |
BKH
|
Keller D Erik
Sr VP Chief Info Officer |
BUY
Grant, award, or other acquisition
|
Direct | 306 Added 2.82% |
$18,390
$60.1 p/Share
|
Feb 12
2025 |
CENT
|
Brooks Pennington Iii |
BUY
Grant, award, or other acquisition
|
Direct | 3,647 Added 8.29% |
-
|
Feb 12
2025 |
APO
|
Martin Kelly
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 36,604 Reduced 8.74% |
$6,067,113
$165.75 p/Share
|
Feb 12
2025 |
BKH
|
Kimberly F Nooney
SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 107 Reduced 0.22% |
$6,430
$60.1 p/Share
|
Feb 12
2025 |
BKH
|
Kimberly F Nooney
SVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 254 Added 0.51% |
$15,265
$60.1 p/Share
|
Feb 12
2025 |
BKD
|
Lee S Wielansky
Director |
BUY
Grant, award, or other acquisition
|
Direct | 32,454 Added 11.75% |
-
|
Feb 12
2025 |
NSIT
|
James A. Morgado
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 485 Reduced 5.38% |
$80,679
$166.35 p/Share
|
Feb 12
2025 |
NSIT
|
James A. Morgado
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,629 Added 15.31% |
-
|
Feb 12
2025 |
NUS
|
Ryan S Napierski
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 17,694 Added 4.52% |
-
|
Feb 12
2025 |
PRAX
|
Marcio Souza
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 401 Reduced 0.74% |
$34,245
$85.4 p/Share
|
Feb 12
2025 |
PRAX
|
Lauren Mastrocola
Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 40 Reduced 0.38% |
$3,416
$85.4 p/Share
|
Feb 12
2025 |
CENT
|
Brendan Dougher |
BUY
Grant, award, or other acquisition
|
Direct | 3,647 Added 18.47% |
-
|
Feb 12
2025 |
MDLZ
|
Luca Zaramella
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 23,677 Reduced 6.41% |
$1,434,826
$60.6 p/Share
|
Feb 12
2025 |
MDLZ
|
Luca Zaramella
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 58,941 Added 13.75% |
-
|
Feb 12
2025 |
VRTX
|
Charles F Wagner Jr
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,655 Added 9.22% |
-
|
Feb 12
2025 |
BKD
|
Claudia Drayton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 17,469 Added 35.71% |
-
|
Feb 12
2025 |
MUSA
|
R Andrew Clyde
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 12,806 Reduced 5.48% |
-
|
Feb 12
2025 |
MUSA
|
R Andrew Clyde
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 29,608 Added 11.25% |
-
|
Feb 12
2025 |
APO
|
Whitney Chatterjee
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 29,548 Reduced 25.2% |
$4,897,581
$165.75 p/Share
|
Feb 12
2025 |
JILL
|
Claire Spofford
President & CEO |
SELL
Open market or private sale
|
Direct | 6,031 Reduced 5.15% |
$151,136
$25.06 p/Share
|
Feb 12
2025 |
CENT
|
Mary Beth Springer |
BUY
Grant, award, or other acquisition
|
Direct | 3,647 Added 15.3% |
-
|
Feb 12
2025 |
CNP
|
Darin M Carroll
SVP Electric Business |
BUY
Grant, award, or other acquisition
|
Direct | 7,827 Added 18.21% |
-
|
Feb 12
2025 |
BKD
|
Vicki L Freed
Director |
BUY
Grant, award, or other acquisition
|
Direct | 32,454 Added 16.05% |
-
|
Feb 12
2025 |
EXPE
|
Robert J Dzielak
Chief Legal Officer & Sec'y |
SELL
Open market or private sale
|
Direct | 4,869 Reduced 6.01% |
$988,407
$203.0 p/Share
|
Feb 12
2025 |
ENS
|
David M Shaffer
CEO |
SELL
Open market or private sale
|
Direct | 15,662 Reduced 16.89% |
$1,569,019
$100.18 p/Share
|
Feb 12
2025 |
ENS
|
David M Shaffer
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,662 Added 14.45% |
$1,071,280
$68.4 p/Share
|
Feb 12
2025 |
APO
|
Louis Jacques Tanguy
Chief Acct. Off. & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 2,279 Reduced 7.77% |
$377,744
$165.75 p/Share
|
Feb 12
2025 |
UMBF
|
James D Rine
President |
SELL
Payment of exercise price or tax liability
|
Direct | 388 Reduced 0.52% |
$43,820
$112.94 p/Share
|
Feb 12
2025 |
VITL
|
Russell Diez Canseco
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 44,970 Reduced 6.24% |
$1,586,091
$35.27 p/Share
|
Feb 12
2025 |
VITL
|
Russell Diez Canseco
PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 52,500 Added 6.79% |
$279,825
$5.33 p/Share
|
Feb 12
2025 |
ALTM
|
Paul W Graves
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 668,731 Added 33.42% |
-
|
Feb 12
2025 |
MUSA
|
Renee M Bacon
SVP, Sales & Ops & CMO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,228 Reduced 13.41% |
-
|
Feb 12
2025 |
MUSA
|
Renee M Bacon
SVP, Sales & Ops & CMO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,838 Added 23.66% |
-
|
Feb 12
2025 |
UMBF
|
Ram Shankar
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 111 Reduced 0.35% |
$12,536
$112.94 p/Share
|
Feb 12
2025 |
MRNA
|
Shannon Thyme Klinger
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,068 Reduced 4.75% |
$33,033
$30.93 p/Share
|
Feb 12
2025 |
MRNA
|
Shannon Thyme Klinger
Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,047 Added 8.34% |
-
|
Feb 12
2025 |
BCPC
|
Daniel E Knutson |
BUY
Grant, award, or other acquisition
|
Direct | 980 Added 13.98% |
-
|
Feb 12
2025 |
BCPC
|
Olivier Rigaud |
BUY
Grant, award, or other acquisition
|
Direct | 980 Added 39.2% |
-
|
Feb 12
2025 |
BCPC
|
Kathleen B Fish |
BUY
Grant, award, or other acquisition
|
Direct | 980 Added 27.69% |
-
|
Feb 12
2025 |
BCPC
|
David B Fischer |
BUY
Grant, award, or other acquisition
|
Direct | 980 Added 8.93% |
-
|
Feb 12
2025 |
HON
|
Anne T Madden
SrVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 530 Reduced 1.2% |
$108,793
$205.27 p/Share
|
Feb 12
2025 |
HON
|
Anne T Madden
SrVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 1,215 Added 2.69% |
-
|
Feb 12
2025 |